APPLICATION OF ORGANIC COMPOUND FOR TREATMENT OF NUNAN SYNDROME

摘要

1. The use of a compound of formula (I) :, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of Noonan syndrome. 2. The use according to claim 1, wherein the Noonan syndrome is a genetic disorder characterized by short stature, congenital heart disease (pulmonary valve stenosis), hypertrophic cardiomyopathy, developmental delays, chest deformities, bleeding disorders and a characteristic configuration of facial features, including, but not limited to, a wide or pterygoid neck, wide-set eyes and / or low-set auricles. 3. The use according to any one of paragraphs. 1-2, in which the drug is intended to treat a warm-blooded animal in need of it suffering from Noonan syndrome. 4. The use of claim 3, wherein the warm-blooded animal is a human being. A method of treating Noonan syndrome, comprising administering to a warm-blooded animal in need thereof a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof. A method of treating Noonan syndrome according to claim 5, in which Noonan syndrome is a genetic disorder characterized by short stature, congenital heart disease (pulmonary valve stenosis), hypertrophic cardiomyopathy, developmental delays, chest deformities, bleeding disorders and a characteristic configuration of facial features including, but not limited to, the wide or pterygoid neck, wide-set eyes and / or low-set auricles. 7. A method for the treatment of Noonan syndrome according to claim 5 and�